The global landscape of infectious diseases is in constant flux, with new pathogens frequently emerging from zoonotic reservoirs, posing persistent challenges to public health systems worldwide. Among these, vector-borne diseases, particularly those transmitted by ticks, represent a significant and growing concern due to the increasing geographical spread of vectors and the diverse array of microorganisms they can harbor. In a pivotal development, researchers in China have unveiled a previously unrecognized tick-borne virus, provisionally named the Asian longhorned tick nairovirus (ALTNV), which has been linked to a spectrum of human illnesses, from mild febrile conditions to severe, life-threatening complications, especially when co-infecting with other pathogens. This discovery not only resolves a long-standing diagnostic enigma but also underscores the critical need for enhanced surveillance and precise diagnostic methodologies in regions where tick-borne infections are prevalent.
For years, clinicians in certain regions of China observed a perplexing trend: patients presenting with symptoms strikingly similar to those caused by the Dabie bandavirus (DBV), a well-known and often fatal tick-borne pathogen, yet consistently testing negative for its presence. This diagnostic gap created a significant clinical challenge, as the underlying cause of these illnesses remained elusive, complicating treatment decisions and prognosis. Recognizing this unexplained phenomenon, a dedicated team of scientists, primarily from the State Key Laboratory of Pathogen and Biosecurity in Beijing, embarked on a comprehensive investigation to identify the causative agent behind these mysterious febrile cases. Their meticulous work, reported in the prestigious New England Journal of Medicine, culminated in the identification of ALTNV, shedding light on a previously hidden facet of the tick-borne disease burden.
The Dabie bandavirus, the original focus of the diagnostic conundrum, is the etiologic agent of Severe Fever with Thrombocytopenia Syndrome (SFTS), a debilitating and potentially lethal condition first identified in China and subsequently recognized in other East Asian countries like Japan and South Korea. SFTS is characterized by an acute onset of fever, gastrointestinal distress, myalgia, and notably, thrombocytopenia—a dangerously low count of platelets, the blood components essential for clotting. The World Health Organization (WHO) has designated DBV as a priority pathogen, emphasizing the urgency for continued research and public health interventions given its high case-fatality rate, which can range from 10% to 30%. The severity of SFTS and the limitations of current treatment options highlight the critical importance of accurate and timely diagnosis, making the presence of SFTS-like illnesses without DBV detection a pressing medical mystery.
To unravel this enigma, the research team implemented a rigorous surveillance strategy. They collected biological samples from individuals who had reported recent tick bites and were receiving care at designated sentinel hospitals located in areas of China known for the circulation of tick-borne viruses. Utilizing advanced molecular techniques, specifically RNA sequencing and viral isolation, the scientists systematically screened these samples. This painstaking process allowed them to detect unique genetic signatures that did not correspond to any known pathogens, ultimately leading to the successful isolation and characterization of the novel virus. This discovery exemplifies the power of robust pathogen surveillance programs and state-of-the-art laboratory diagnostics in identifying emerging threats.
Subsequent genetic analyses provided definitive evidence of ALTNV’s distinct identity. The virus was classified within the orthonairovirus genus, a group of RNA viruses belonging to the family Nairoviridae. This family includes other significant human pathogens, such as the Crimean-Congo Hemorrhagic Fever virus, known for causing severe hemorrhagic fevers. A crucial finding from the genetic sequencing was that ALTNV’s proteins exhibited less than 80% amino acid sequence similarity to those of any other recognized species within the orthonairovirus genus. This significant divergence in genetic makeup firmly established ALTNV as a genetically distinct species, warranting its classification as a novel pathogen. Further laboratory experiments corroborated these findings. Researchers successfully cultivated ALTNV in laboratory cell cultures using human serum samples containing the viral RNA, demonstrating its ability to replicate in human cells. Immunofluorescence assays, which detect viral antigens, confirmed the identity of the growing virus as ALTNV. Electron microscopy revealed ultrastructural features characteristic of other orthonairoviruses, while additional experiments showcased the virus’s capacity to propagate in various types of mammalian cells, solidifying its biological characterization.
The epidemiological investigation revealed the widespread presence of ALTNV among the patient population. Out of 3,163 individuals included in the study, a significant proportion—10.4%—tested positive for ALTNV, indicated either by the detection of viral RNA or the presence of immunoglobulin M (IgM) antibodies, which typically signify a recent infection. This prevalence was even more pronounced among the subgroup of patients who had presented with SFTS-like symptoms but tested negative for DBV; within this specific cohort, an alarming 15.1% were found to be infected with ALTNV. This finding directly addressed the initial diagnostic gap, confirming that ALTNV was indeed responsible for a substantial number of previously undiagnosed tick-borne illnesses.
The clinical profile of patients solely infected with ALTNV painted a picture of a milder, though still symptomatic, illness. The most frequently reported symptom among these individuals was profound fatigue, affecting 84% of cases. Gastrointestinal disturbances, including nausea, vomiting, or diarrhea, were also highly prevalent, reported by 80% of patients. While less common than fatigue or GI issues, thrombocytopenia—the characteristic low platelet count associated with DBV—was observed in 38% of ALTNV-only patients. Additionally, 36% of these individuals exhibited elevated aminotransferase concentrations, an indicator of inflammation or injury to the liver or other tissues. Encouragingly, all patients diagnosed solely with ALTNV ultimately recovered completely, suggesting that mono-infection with this novel virus typically leads to a self-limiting disease course without fatal outcomes.
However, the most concerning aspect of the discovery emerged when researchers analyzed cases of co-infection. The study identified 38 patients who were simultaneously infected with both ALTNV and DBV. The clinical outcomes for this group were markedly more severe than for those infected with DBV alone. Patients with co-infections experienced respiratory symptoms at a significantly higher rate, affecting 61% compared to 38% of DBV-only patients. Kidney impairment was also substantially more common in co-infected individuals, occurring in 84% of cases versus 66% in the DBV mono-infection group. Tragically, seven of the 38 co-infected patients succumbed to their illness, resulting in a case-fatality rate of 18.4% within this specific cohort. This stark difference in severity and mortality highlights a synergistic effect between the two viruses, where concurrent infection with ALTNV appears to exacerbate the already dangerous course of SFTS.
The investigation extended beyond human cases to the vectors themselves. The research team meticulously examined 47,428 ticks collected from 15 distinct provinces across China, revealing the broad geographical distribution of ALTNV in the environment. Viral RNA for ALTNV was detected in 1.3% of the total tick population sampled. Among the various tick species analyzed, the highest prevalence of ALTNV was found in Haemaphysalis longicornis, commonly known as the Asian longhorned tick, with 1.8% of these ticks testing positive for the virus. This finding is particularly significant because H. longicornis is a highly aggressive and adaptable tick species, notorious for its broad host range and its ability to reproduce parthenogenetically, meaning a single female can establish a new population without a male. This characteristic allows for rapid proliferation and makes it a highly efficient vector. Laboratory experiments further cemented the role of H. longicornis as a primary vector by demonstrating its capacity to effectively transmit ALTNV to mice, providing robust evidence for its competence in viral dissemination. The Asian longhorned tick is also a known vector for DBV, meaning both viruses share the same primary arthropod host.
The implications of ALTNV’s discovery are profound for public health, particularly in regions where SFTS is endemic. The co-circulation of ALTNV and DBV in the same geographical areas, coupled with their shared tick vector, creates a complex diagnostic challenge. Clinicians must now consider the possibility of either mono-infection with ALTNV, mono-infection with DBV, or a potentially more severe co-infection when encountering patients with tick-borne febrile illnesses. This necessitates the development and implementation of improved differential diagnostic tools capable of rapidly and accurately distinguishing between these infections. Such tools are crucial not only for guiding appropriate patient management and supportive care but also for understanding the true epidemiological burden of tick-borne diseases.
The emergence of ALTNV serves as a powerful reminder of the dynamic nature of pathogen discovery and the continuous need for vigilance. It underscores the importance of a "One Health" approach, integrating human, animal, and environmental health surveillance to detect and respond to emerging threats effectively. Future research will likely focus on understanding the full spectrum of ALTNV disease, potential treatments, and preventative strategies, including improved tick control measures. This discovery in China is a testament to the ongoing global effort to characterize and combat infectious diseases, ensuring that our understanding of the microbial world keeps pace with its ever-evolving challenges.
About the Author
